This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Biocon Limited. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chikamaghur, IN (2017)
- Chikkamagaluru, IN (2021)
Company Filing History:
Years Active: 2017-2021
Title: Innovations of Dharshan Jakkali Chandregowda
Introduction
Dharshan Jakkali Chandregowda is a notable inventor based in Chikkamagaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and processes. With a total of 2 patents, his work showcases a commitment to innovation and improvement in medicinal chemistry.
Latest Patents
Chandregowda's latest patents include the "Crystalline linagliptin intermediate and process for preparation of linagliptin." This invention provides novel crystalline forms B1 & B2 of the linagliptin intermediate and outlines methods for their production. Another significant patent is for the "Process for the preparation of 2-amino-1,3-propane diol compounds and salts thereof." This disclosure relates to safe and commercially feasible processes for synthesizing 2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol and its hydrochloride salt, highlighting improved efficacy and various advantages.
Career Highlights
Chandregowda is currently associated with Biocon Limited, a leading biopharmaceutical company. His work at Biocon has allowed him to focus on innovative solutions in drug development and synthesis. His contributions have been instrumental in advancing the company's research initiatives.
Collaborations
Chandregowda has collaborated with notable coworkers such as Kothakonda Kiran Kumar and Chandrashekar Aswathanarayanappa. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Dharshan Jakkali Chandregowda's contributions to the field of pharmaceuticals through his patents and work at Biocon Limited exemplify the spirit of innovation. His dedication to developing new compounds and processes continues to impact the industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
